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Background: To evaluate the use of guided bone regeneration with xenograft to prevent periodontal defect in the 
distal aspect of the second molar after the surgical removal of the mandibular third molar.
Material and Methods: Three electronic databases (Pubmed, Cochrane Library and Scopus) were searched in 
April 2020. Randomized clinical trials in non-smokers and healthy patients, with at least six months follow-
up, comparing periodontal probing depth, clinical attachment level, alveolar bone level and adverse events were 
selected by two independent investigators. The risk of bias assessment of the selected studies was evaluated by 
means of the Cochrane Collaboration’s Tool. Finally, a meta-analysis of the outcomes of interest was performed.
Results: Despite 795 articles were found in the initial search, only three randomized controlled clinical trials were 
included. Pooled results favoured the use of the xenograft plus collagen membrane over the spontaneous healing 
in terms of periodontal probing depth gain (MD=2.36; 95% CI 0.69 to 4.03; P=0.005) and clinical attachment level 
gain (MD=2.52; 95% CI 0.96 to 4.09; P=0.002). No other statistically significant differences were found.
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Introduction
Extraction of mandibular third molar (M3M) is a very 
widespread practice in dentistry. Although its indica-
tion is clear when provoking symptoms or disease (e.g. 
infection, non-restorable caries, periodontal disease, 
root resorption), currently the prophylactic extraction 
remains a controversial issue (1). Indeed, the decision-
making for removal of wisdom teeth has been discussed 
in the literature and some countries such as Finland, 
France, The United Kingdom or Spain, have made their 
own clinical practice guidelines, exhibiting discrepan-
cies between them, especially about the prophylactic 
extraction of the M3M (2-4).
Periodontal disease on the mandibular second molar 
(M2M) is one of the primary reasons for the treatment 
of M3M (5). There are predisposing factors associated 
to the appearance of bony periodontal defects in the dis-
tal aspect of the M2M after the surgical removal of the 
M3M such as patient’s age (older than 25 years), posi-
tion of the wisdom tooth or pre-existing periodontal de-
fect. Knutsson et al. (6) described that mesioangular or 
horizontal M3M with a large contact with M2M had a 
greater risk of periodontal postoperative complications. 
Additionally, other studies have shown that the surgery 
itself can also cause a residual intrabony defect behind 
the M2M (7-9).
To prevent periodontal defects after the M3M extrac-
tion, various treatment modalities have been sug-
gested, including different flap designs, soft-tissue 
suturing, and different bone and tissue regeneration 
techniques. In the context of periodontal regeneration 
therapy, bone substitutes such as autologous bone, al-
lografts, xenografts or alloplastic grafts and occlusive 
membranes have been broadly studied (10,11). Each 
material is associated with some advantages and dis-
advantages, so their selection should depend on the 
clinical scenario, as well as, the preferences of the cli-
nician and the patient (12).
Among these bone substitutes, the xenograft has been 
widely used in the field of bone reconstruction since it 
is a safe and a well-documented osteoconductive mate-
rial with a low resorption rate. Due to its chemical com-
position and its trabecular structure, the xenograft has 
proven to be a good scaffold for cell growth, and thus, 
for bone regeneration (13,14).
Despite previous systematic reviews have been pub-
lished on this topic, none of them compared solely the 
xenograft to the spontaneous healing. Thus, the aim of 
the present systematic review and meta-analysis was to 
gather the published randomized clinical trials to deter-
mine whether bone regeneration with xenograft is use-
ful to prevent periodontal defects in the distal aspect 
of the M2Ms after the surgical extraction of the M3M.
Material and Methods 
This systematic review and meta-analysis was conduct-
ed in accordance with the statements of “Preferred Re-
porting Items for Systematic Reviews and Meta-Analy-
ses” (PRISMA) (15).
- Eligibility criteria
The inclusion criteria were depicted in Table 1. We in-
cluded articles that met the following eligibility criteria:
(P) Population: Non-smokers and healthy patients that 
underwent a M3M extraction.
Conclusions: Within the limitations of the present review, the xenograft plus collagen membrane exhibited better 
periodontal results than spontaneous healing without increasing postoperative complications. However, future well-
designed studies with larger samples are required to confirm our results.
Key words: Third molar, tooth extraction, bone regeneration, xenograft.
Population Healthy patients who underwent a M3M extraction
Intervention Bone regeneration with xenograft
Comparison Spontaneous healing
Outcomes
Periodontal parameters registered on the distal site of the M2M
- PPD changes 
- CAL changes
- ABL changes 
- Adverse events
Study design RCTs with at least 6 months follow-up.
Abbreviations: ABL; Alveolar bone level, CAL; Clinical attachment level, M2M; Mandibular second molar, 
M3M; Mandibular third molar, PPD; Periodontal probing depth, RCTs; Randomized clinical trials, SRP; 
Scaling and root planning.
Table 1: PICOS items. P; population, I; intervention, C; comparison, O; outcomes, S; study design.
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characteristics, surgical interventions, postoperative 
follow-up and the outcomes. Finally, we contacted with 
the authors of the selected studies for clarification when 
data were missing or incomplete.
- Risk of bias assessment
Two independent reviewers (V.R-R. and J.T-S.) evaluat-
ed the risk of bias of each article by means of "Cochrane 
Handbook for systematic reviews of interventions, ver-
sion 5.1.0" (16). We evaluated as low, unclear or high 
risk of bias the following six quality criteria: random 
sequence generation, allocation concealment, patient 
blinding, outcome blinding, incomplete outcome data 
and selective reporting. Finally, a third independent 
reviewer (MÁ.S-G.) resolved any disagreement during 
this step.
- Statistical analysis
Odds ratio (OR) with 95% confidence intervals (CI) 
was used for adverse events outcome. In order to esti-
mate the size of the effect, mean difference (MD) and 
standard deviation (SD) were used for PPD, CAL and 
ABL. A pairwise meta-analysis was conducted using 
RevMan software (Review Manager version 5.3; The 
Cochrane Collaboration, Copenhagen, Denmark) using 
M3M as the statistical unit in split-mouth studies. We 
selected the random effect model due to methodological 
and clinical heterogeneity expected across the included 
studies (17). In addition, significant heterogeneity was 
interpreted when I2 value was >50 (18). Statistical sig-
nificance was defined as P < 0.05 for all analyses.
Results
- Study selection and description
The initial electronic and manual search rendered 795 
references. After the removal of the duplicates and the 
irrelevant articles based on their title and abstracts, 7 
full texts were screened. Inter-reviewer agreement be-
tween the investigators (V.R-R. and J.T-S.) was 100% 
with a Cohen’s kappa index of 1 (perfect agreement).
The reasons for rejecting four articles were as follows: 
an insufficient follow-up (19), duplicates studies (20,21) 
and included smoker patients (22). Finally, for the pres-
ent review three articles (23-25) were selected (Fig. 1).
- Risk of bias assessment
As shown on Fig. 2, one article had a low risk of bias 
(25), while the studies published by Hassan et al. (24) 
and Andrade-Munhoz et al. (23) were classified as hav-
ing unclear and high risk of bias, respectively.
- Extraction Data
We pooled the results of three articles (23-25) for as-
sessing the xenograft alone or the xenograft covered by 
a collagen membrane after the removal of the M3M. The 
selected studies had a split-mouth design that comprised 
98 patients (17 dropouts). Finally, this systematic review 
involves 81 patients with 162 M3Ms were included for 
the qualitative and quantitative analysis (Table 2).
(I) Intervention: Bone regeneration using bovine xeno-
graft with or without membrane.
(C) Comparison: Spontaneous healing.
(O) Outcomes: Periodontal parameters evaluated on 
the distal site of the M2M. We registered the periodon-
tal probing depth (PPD), the clinical attachment level 
(CAL), the alveolar bone level (ABL) the number of ad-
verse events.
(S) Study design: Randomized clinical trials (RCTs) 
with at least 6 months follow-up. We did not apply any 
restriction in terms of language and year of publication.
According to these PICOS question, we designed the 
following clinical question: In non-smoker and healthy 
patients who need the removal of the M3M, what ben-
efit does the use of bone regeneration with xenograft 
in terms of PPD, CAL, ABL and adverse events when 
compared to spontaneous healing have?
- Search strategy
Applying the following search strategy: (“molar, third” 
[MH] OR third molar* [TIAB] OR wisdom teeth* 
[TIAB] OR wisdom tooth* [TIAB] OR 3rd molar* 
[TIAB]) AND (“tooth extraction” [MH] OR extraction* 
[TIAB] OR removal* [TIAB] OR exodontia* [TIAB]) 
AND (“regeneration” [MH] OR “wound healing” [MH] 
OR “guided tissue regeneration, periodontal” [MH] OR 
“bone substitutes” [MH] OR guided bone regenera-
tion* [TIAB] OR xenograft* [TIAB] OR “membranes, 
artificial” [MH] OR membrane* [TIAB] OR barrier* 
[TIAB]) NOT (“platelet rich fibrin”), Pubmed, Scopus 
and Cochrane Library databases were searched by two 
independent investigators (V.R-R. and J.T-S.) in April 
2020. Additionally, we carried out a manual search of 
articles published during the last 10 years in “Medicina 
Oral Patología Oral y Cirugía Bucal”, “Journal of Oral 
and Maxillofacial Surgery”, “International Journal of 
Oral and Maxillofacial Surgery”, “Journal of Clinical 
Periodontology”, “Journal of Periodontology”, “Clinical 
Oral Investigations”, “Oral Surgery Oral Medicine Oral 
Pathology Oral Radiology”, “Journal of Dentistry" and 
"Journal of the American Dental Association”.
- Selection of studies
Two independent reviewers (V.R-R. and J.T-S.) carried 
out the selection of studies. After we removed the dupli-
cates and the articles based on their title and abstracts, 
we selected the papers according to the inclusion crite-
ria. Cohen’s kappa statistic was computed to measure 
the level of agreement between the two investigators. 
Any disagreement during the article selection was 
resolved thanks to one independent investigator 
(MÁ.S-G.).
- Data extraction
The data extraction process was performed by two in-
dependent researchers (V.R-R. and J.T-S.). The extrac-
tion tables included the name of the authors, country 
of origin, year of publication, study design, participant 
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Authors Andrade-Munhoz et al. (23) Hassan et al. (24) Sammartino et al. (25)
Year 2011 2012 2009
Country Brazil Saudi Arabia Italy






Non-smokers and healthy 
patients with impacted M3M 
symmetrically positioned
Non-smokers and healthy pa-
tients with bilateral and hori-
zontal impacted M3M
Non-smokers and healthy patients 
with bilateral and mesioangular or 
horizontal impacted M3Ms. 
Participants were included if authors 
recorded before the surgery a PPD 
>or= 7mm and CAL >or= 6mm in the 












Comparison Spontaneous healing Spontaneous healing Spontaneous healing
Follow-up (months) 24 12  72
Abbreviations: ABL; Alveolar bone level, CAL; Clinical attachment level, CM; Collagen membrane, M2M; Mandibular second molar, M3M; 
Mandibular third molar, PPD; Periodontal probing depth, SRP; Scaling and root planning.
Fig. 1: PRISMA flow chart of the study selection process.
Table 2: Description of the selected studies.
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collagen membrane revealed a statistically greater PPD 
and CAL gain than spontaneous healing at 12 months of 
follow-up after the M3M extraction (P<0.05).
Regarding ABL gain, one paper (23) reported higher 
values comparing xenograft covered by a collagen 
membrane (MD= 2.36; 95%CI 0.69 to 4.03; P=0.005) 
and spontaneous healing.
The results of the study by Sammartino et al. (25) 
showed that the xenograft plus the collagen membrane 
group had a significantly better results in terms of PPD 
and CAL than the group that used the xenograft alone 
(P<0.05).
None of the papers revealed statistically significant dif-
ferences between groups with regard to adverse events. 
Out of the two studies that reported this outcome, three 
postoperative infections occurred in the grafted group 
and one in the control group (23).
- Quantitative synthesis
The same studies included in the qualitative synthesis 
were used to perform a pairwise meta-analysis compar-
ing the use of xenograft covered by a collagen mem-
brane after the removal of the M3M (23-25). We were 
unable to meta-analyse the adverse events outcome due 
to lack of data.
The results of two articles (24,25) were pooled for PPD 
and CAL analysis. These studies involved 73 M3Ms in 
total. Quantitative analysis favoured the use of the xe-
nograft plus collagen membrane over the spontaneous 
healing in terms of PPD gain (MD= 2.36; 95%CI 0.69 to 
4.03; P=0.005; I2=97%) (Fig. 3, Table 3) and CAL gain 
(MD=2.52; 95%CI 0.96 to 4.09; P=0.002; I2=95%) (Fig. 
3, Table 3). No statistically significant differences were 
found in terms of ABL changes (Fig. 3, Table 3).
Fig. 2: The Cochrane Collaboration’s tool for assessing risk of bias 
for randomized controlled trials.
- Qualitative synthesis
Across the three included trials in the present review 
(23-25), one of these studies had a multi-arm design 
(25). All included papers compared xenograft plus col-
lagen membrane versus spontaneous healing (23-25), 
while the multi-arm study had also a group comparing 
the xenograft without membrane (25). 
In two trials (24,25), the xenograft covered or not by a 
Fig. 3: Forest plots for mean difference of periodontal probing depth reduction (PPD) (A), mean difference of clinical attachment level gain 
(CAL) (B) and mean difference of alveolar bone level gain (ABL) (C).
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Discussion
The purpose of the present study was to answer the fol-
lowing clinical question: in M3M post-extraction sites, 
what benefit does the use of bone regeneration with xe-
nograft in terms of PPD, CAL, ABL and adverse events 
when compared to spontaneous healing have? After 
performing the meta-analysis, our results revealed 
a significant PPD reduction and CAL gain compar-
ing guided bone regeneration (xenograft plus collagen 
membrane) versus spontaneous healing. Moreover, the 
bone filling with xenograft and the spontaneous healing 
resulted in similar ABL gain and number of postopera-
tive complications.
Periodontal defect in the distal site of the M2M is a 
common finding in patients undergoing M3M extrac-
tion. In fact, through the selected studies, up to 50% of 
the cases exhibited PPD of at least 7mm before the in-
tervention (24,25). This resembles the results of Garaas 
et al. (26) in which 65% of the patients had a PPD ≥4 
mm at the distal site of the M2M.
The age of patients has their own relevance in bone re-
generation of M3M sites. Kugelberg (27) demonstrated 
that patients older than 25 years old have a poor peri-
odontal healing, which might cause periodontal pockets 
behind the M2M. In relation to this, the maximum age 











(2011) (2012) (2009) (2009)
Intervention     
Experimental group xenograft + collagen membrane
xenograft + collagen 
membrane
xenograft + collagen 
membrane xenograft
Control spontaneous healing spontaneous healing spontaneous healing spontaneous healing
Nº. patients (NºM3M) (dropouts)     
Test 39 (39) (17) 14 (14) (0) 15 (30) (0) 15 (30) (0)
Control 39 (39) (17) 14 (14) (0) 15 (15) (0) 15 (15) (0)
Age of participants, years     
Experimental group, (Range) 15-25 32 (2.03) 21-30 21-30
Spontaneous healing, (Range) 15-25 32 (2.03) 21-30 21-30
SRP of distal M2M     
 Experimental group Yes Yes Yes Yes
 Spontaneous healing Yes Yes Yes Yes
Ostectomy Not reported Yes Yes Yes
Socket debridement Yes Yes Yes Yes
PPD reduction, mm     
Experimental group
Not reported
4.4 (0.6) 4.5 (0.5) 3.7 (0.2)
Spontaneous healing 2.9 (0.7) 1.3 (0.5) 1.3 (0.5)
Mean difference (95% CI) 1.50 (1.02, 1.98) 3.20 (2.89, 3.51) 2.40 (2.14, 2.66)
p value <0.001*  <0.001* <0.001*
CAL gain, mm     
Experimental group
Not reported
3.0 (1.0) 3.6 (0.5) 2.9 (0.5)
Spontaneous healing 1.3 (0.7) 0.3 (0.6) 0.3 (0.6)
Mean difference (95% CI) 1.70 (1.06, 2.34) 3.30 (2.95, 3.65) 2.60 (2.25, 2.95)
p value <0.001* <0.001* <0.001*
ABL gain, mm     
Experimental group 1.34 (0.8) 3.6 (0.2)
Not reported Not reported Spontaneous healing 1.25 (1.6) 1.2 (0.4)Mean difference (95% CI) 0.09 (-0.76, 0.94) 2.40 (2.17, 2.63)
p value 0.8370  <0.001*
Adverse events     
Experimental group, Nº 3 0
Not reported Not reportedSpontaneous healing, Nº 1 0OR (95% CI) 3.17 (0.31, 31.86) Not estimable
p value 0.328 Not applicable
Abbreviations: ABL; Alveolar bone level, CAL; Clinical attachment level, CI; Confidence interval, CM; Collagen membrane, M2M; Man-
dibular second molar, M3M; Mandibular third molar, OR; Odds ratio, PPD; Periodontal probing depth, SRP; Scaling and root planning.
Table 3: Comparison of the selected studies.
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reaches 35 years old with impacted M3Ms, so they 
could obtain a greater benefit from xenograft bone re-
generation to prevent future periodontal defects.
Over the years, different techniques (i.e. incision de-
signs, soft-tissue suturing, scaling and root planning 
or periodontal regeneration) and materials (i.e. platelet 
concentrates, bone substitutes or occlusive membranes) 
have been investigated to solve this problem. A recent 
meta-analysis published by Chen et al. (28) showed a 
possible benefit of leaving a portion of gingiva around 
the M2M during the incision of the M3M extraction. 
Regarding other bone regeneration biomaterials, the 
results of this review have shown some discrepancies. 
Ge et al. (29) did not show significant results in PPD 
reduction and CAL gain at 6 and 12 months of follow-
up with autologous bone substitute. Another autologous 
material that, unlike xenograft (23-25), has shown poor 
results in bone regeneration was platelet rich plasma 
(PRP), but instead, it has shown an improvement in soft 
tissue healing (30,31).
On the other hand, regarding the ABL gain, neither al-
lograft (32,33) nor alloplastic (34) biomaterials showed 
significant improvements which could be in line with 
xenograft, specifically with the included study by An-
drade-Munhoz et al. (23) In contrast, Hassan et al. (24) 
obtained a significant ABL gain with the use of xeno-
graft at 12 months of follow-up. It should be noted that 
Andrade-Munhoz et al. (23) used a new type of xeno-
graft that is only marketed in Brazil, unlike the other 
2 articles analysed in this systematic review (24,25), 
which used a type of well-known xenograft, supported 
by numerous studies.
Regarding the use of resorbable or non-absorbable 
membrane there are no statistically significant differ-
ences between them, however, second surgery is avoid-
ed when the resorbable membranes are used (35,36). In 
this review, only one study (25) compared the xenograft 
with or without membrane and the best outcomes were 
for the membrane group.
Generally, bone regeneration increases the risk of post-
operative complications (29,32,34), however, among the 
included studies, we did not obtain significant compli-
cations (23).
Although it would be interesting to obtain histologi-
cal studies to observe whether tissue regeneration is 
formed, it is not clinically relevant since the objective of 
bone regeneration is that the patients do not have peri-
odontal defects, being able to maintain stable over time. 
Across the included studies, only one of them (25) pro-
vided histological results showing that with the use of 
a collagen membrane the level of xenogeneic particles 
was lower and more mature osteoid matrix (better bone 
quality) was observed at 6 months. Nevertheless, it is 
not essential since we have not evaluated this outcome.
In this review, all included studies (23-25) performed 
a scaling and root planning either in experimental or 
control groups. This procedure has been shown to re-
move plaque and calculus behind M2M and it conse-
quently improves periodontal healing (37) therefore, the 
included studies could have been benefited from this 
procedure.
There were several limitations related to the present 
study that must be mentioned. Firstly, only three papers 
which compared the guided bone regeneration with 
xenograft and the spontaneous healing were able to be 
included in our meta-analysis. There were no studies 
to compare by a meta-analysis the effectiveness of the 
xenograft without a collagen membrane. Moreover, the 
limited number of patients and M3M included together 
with the fact that only one paper of the selected stud-
ies had a low risk of bias, did not allow to make robust 
conclusions. Another possible drawback of this meta-
analysis was the substantial heterogeneity across the se-
lected studies. Thus, authors recommend being cautious 
with the results of the present review.
Conclusions
Within the above-mentioned limitations, it can be con-
cluded that guided bone regeneration with xenograft 
and collagen membrane exhibited greater PPD reduc-
tion and CAL gain in the distal aspect of the M2M after 
the surgical extraction of the M3M than spontaneous 
healing. However, to confirm our results well-conduct-
ed investigations with larger samples and with a longer 
follow-up are needed.
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